Treprostinil Ultrasonic Nebulizer ( DrugBank: Treprostinil )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
85	特発性間質性肺炎	3

85. 特発性間質性肺炎

---

臨床試験数 : 598 /  薬物数 : 435 - (DrugBank : 116) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 210

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05255991 (ClinicalTrials.gov)	September 2022	15/2/2022	Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis	A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2)	Idiopathic Pulmonary Fibrosis;Interstitial Lung Disease	Drug: Placebo;Drug: Inhaled Treprostinil;Device: Treprostinil Ultrasonic Nebulizer	United Therapeutics	NULL	Not yet recruiting	40 Years	N/A	All	396	Phase 3	NULL
2	NCT04905693 (ClinicalTrials.gov)	June 2022	20/5/2021	Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis	An Open-label Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis;Interstitial Lung Disease	Drug: Inhaled Treprostinil;Device: Treprostinil Ultrasonic Nebulizer	United Therapeutics	NULL	Not yet recruiting	40 Years	N/A	All	792	Phase 3	NULL
3	NCT04708782 (ClinicalTrials.gov)	June 1, 2021	12/1/2021	Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis	A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis;Interstitial Lung Disease	Drug: Placebo;Drug: Inhaled Treprostinil;Device: Treprostinil Ultrasonic Nebulizer	United Therapeutics	NULL	Recruiting	40 Years	N/A	All	396	Phase 3	United States